A dual-target GUCY2C-CD3 binder improves T-cell synapse formation and tumor cell killing in gastrointestinal cancers.
Deleting 1-18 C-terminal residues from OaPAC boosts photoactivation efficiency, enabling lower light use and reducing photodamage risk.
A pre-targeting probe binds immune cells before payload delivery, helping reduce off-target toxicity and support flexible drug loading.
Isolating the pyripyropene biosynthetic gene cluster resolves low productivity bottlenecks by enabling targeted genetic transformation of host strains.
Recombinant VHH binding proteins neutralize anthrax and botulinum toxins through specific molecular recognition.
Butelase 1 enzyme recognizes Asx-His-Val motifs to cleave sorting sequences and ligate residues, eliminating slow overnight incubation times.
Deletions in adenylate cyclase regulatory domains boost cAMP levels to drive fine chemical synthesis.
Targeted mutations in squalene-hopene cyclase resolve the contradiction between cyclization efficiency and stereospecificity during terpene processing.
Reduced AC-CaM affinity enables high-sensitivity detection of toxic proteins by minimizing background noise while maintaining selectable traits.